Skip to content
CorpDev.Org

CorpDev.Org

Daily News for Dealmakers

Sunday 15th June 2025
  • Hire Me for M&A/PE Projects!
  • AI Assisted Due Diligence
  • Private Equity
  • Tech, Media & Telecom
  • Financial Services
  • Healthcare & Life Sciences
  • Consumer & Industrial
  • Energy & Utilities
CorpDev.Org

CorpDev.Org

Daily News for Dealmakers

  • Hire Me for M&A/PE Projects!
  • AI Assisted Due Diligence
  • Private Equity
  • Tech, Media & Telecom
  • Financial Services
  • Healthcare & Life Sciences
  • Consumer & Industrial
  • Energy & Utilities

Day: October 3, 2022

L3Harris to Acquire Viasat’s Tactical Data Link Business

L3Harris to Acquire Viasat’s Tactical Data Link Business

  • October 3, 2022
  • 0 Comments
  • By CorpDev
L3Harris Technologies today announced the signing of a definitive agreement to acquire Viasat, Inc.’s Tactical Data Links product line for approximately $1.96 billion, subject to customary...
Posted in Technology, Media and Telecom
Private Equity-Backed Breitling CEO Eyes Deals After Turnaround [Private Equity Insights]

Private Equity-Backed Breitling CEO Eyes Deals After Turnaround [Private Equity Insights]

  • October 3, 2022
  • 0 Comments
  • By CorpDev
On the surface, private equity and Swiss watchmaking aren’t an obvious pairing. One is focused on maximizing returns and reducing costs, while the other relies on highly trained workers, big...
Posted in Private Equity
Why aren’t we seeing more aggressive SaaS M&A? [Mergers and Acquisitions • TechCrunch]

Why aren’t we seeing more aggressive SaaS M&A? [Mergers and Acquisitions • TechCrunch]

  • October 3, 2022
  • 0 Comments
  • By CorpDev
With public stock valuations way down, it's surprising we aren't seeing more aggressive M&A activity from acquisitive companies and private equity alike. Why aren’t we seeing more aggressive...
Posted in Thought Leadership and Education

Conflict Sinks Special Master Plan For Musk-Twitter Disputes [Law360: Mergers & Acquisitions]

  • October 3, 2022
  • 0 Comments
  • By CorpDev
An "unanticipated conflict" scuttled plans to appoint retired U.S. Bankruptcy Judge Christopher S. Sontchi as special master for remaining discovery disputes in Elon Musk's attempt to terminate his...
Posted in Deal Drama
UK take-privates flash on US buyout radar [buyout/ takeover]

UK take-privates flash on US buyout radar [buyout/ takeover]

  • October 3, 2022
  • 0 Comments
  • By CorpDev
UK-listed companies in industrials, telecoms and technology could be potential acquisition targets while consumer brands could be targeted for their low valuation. Source Author: emily.lai
Posted in International
Career Advice From Private Equity’s Leading Women [WSJ Pro – Private Equity]

Career Advice From Private Equity’s Leading Women [WSJ Pro – Private Equity]

  • October 3, 2022
  • 0 Comments
  • By CorpDev
Source Author: unknown
Posted in Thought Leadership and Education
AstraZeneca pays 660% premium for gene therapy firm LogicBio [Deals Market Headlines | Breaking Stock Market News | Reuters]

AstraZeneca pays 660% premium for gene therapy firm LogicBio [Deals Market Headlines | Breaking Stock Market News | Reuters]

  • October 3, 2022
  • 0 Comments
  • By CorpDev
Oct 3 (Reuters) - Shares of LogicBio Therapeutics (LOGC.O) skyrocketed on Monday after Britain's AstraZeneca's (AZN.L) said it would buy the U.S.-based gene therapy developer at a rare 660% premium...
Posted in International
Vodafone, Three UK accelerate talks for merger of British operations [Deals Market Headlines | Breaking Stock Market News | Reuters]

Vodafone, Three UK accelerate talks for merger of British operations [Deals Market Headlines | Breaking Stock Market News | Reuters]

  • October 3, 2022
  • 0 Comments
  • By CorpDev
LONDON, Oct 3 (Reuters) - Vodafone (VOD.L) and CK Hutchison (0001.HK), the owner of Three UK, have accelerated talks about a deal to combine their British operations, Sky News reported on Monday....
Posted in International
AstraZeneca pays 660% premium for gene therapy firm LogicBio [Deals Market Headlines | Breaking Stock Market News | Reuters]

AstraZeneca pays 660% premium for gene therapy firm LogicBio [Deals Market Headlines | Breaking Stock Market News | Reuters]

  • October 3, 2022
  • 0 Comments
  • By CorpDev
Oct 3 (Reuters) - Shares of LogicBio Therapeutics (LOGC.O) skyrocketed on Monday after Britain's AstraZeneca's (AZN.L) said it would buy the U.S.-based gene therapy developer at a rare 660% premium...
Posted in Healthcare and Life Sciences

CorpDev.Org

24×7 real time deals updates for everyone associated with deals.  Bookmark the page!

Daily M&A/PE News In 5 Min

Recent Posts

  • Bojangles Considers $1.5 Billion Sale Amid Surging Demand for Chicken Concepts
  • Pennsylvania House Votes to Scrutinize Private-Equity Healthcare Takeovers
  • BioNTech Consolidates mRNA Leadership with Strategic $1.25 Billion CureVac Acquisition
  • US-China Tech Decoupling Accelerates as Eight Roads Exits 40 Chinese Startups
  • Mitsubishi Estate’s Strategic Play: Acquiring Patron Capital to Dominate European Real Estate Debt Markets

Categories

  • Hire Me for M&A/PE Projects!
  • AI Assisted Due Diligence
  • Private Equity
  • Tech, Media & Telecom
  • Financial Services
  • Healthcare & Life Sciences
  • Consumer & Industrial
  • Energy & Utilities

Daily M&A/PE News In 5 Min

Deals by month

  • June 2025 (99)
  • May 2025 (163)
  • April 2025 (86)
  • January 2025 (53)
  • November 2024 (62)
  • October 2024 (102)
  • September 2024 (97)
  • August 2024 (165)
  • July 2024 (20)
  • March 2023 (7)
  • November 2022 (41)
  • October 2022 (89)
  • September 2022 (190)
  • August 2022 (80)
  • July 2022 (2)
  • June 2022 (79)
  • May 2022 (1)

Copyrights belong to 'Sources' referred to in each article, unless the articles are originally published by CorpDev.org in which case the copyright belongs to CorpDev.org